ALBERTDAVD
Albert David Limited (ALBERTDAVD) Stock Analysis
Albert David Limited is an Indian pharmaceutical company with a long history in veterinary and human healthcare products. It manufactures and markets medicines and animal health products for domestic markets. The company operates as a small listed pharma firm. It is headquartered in India and traded on the exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹791.60
-7.59% 1W | +1.30% 52W
Market Cap
452 CR
P/E Ratio
20
52W High
₹931.9
52W Low
₹579.9
Div. Yield
0.63%
Beta
0.4
50 DMA
₹828.3
200 DMA
₹736.4
Profit Margin
6.2%
Inst. Own.
1.6%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 92 | 93 | 88 | 89 | 89 | 98 | 83 | 75 | 71 | 87 | 90 | 86 | 101 |
| Expenses | 79 | 77 | 80 | 79 | 88 | 92 | 82 | 80 | 81 | 85 | 79 | 83 | 91 |
| Operating Profit | 13 | 16 | 8 | 10 | 1 | 6 | 1 | -5 | -11 | 3 | 11 | 3 | 11 |
| OPM % | 14% | 17% | 9% | 11% | 1.0% | 6% | 0.8% | -6% | -15% | 2.9% | 12% | 3.2% | 10% |
| Other Income | 18 | 12 | 17 | 10 | 23 | 21 | -9 | -5 | 22 | -2 | 12 | -25 | 28 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 |
| Depreciation | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
| Profit before tax | 29 | 27 | 23 | 18 | 22 | 25 | -10 | -12 | 8 | -3 | 20 | -25 | 36 |
| Tax % | 20% | 24% | 20% | 29% | 15% | 28% | -8% | -13% | 6% | 28% | 23% | -15% | 11% |
| Net Profit | 23 | 20 | 19 | 13 | 19 | 18 | -9 | -10 | 8 | -3 | 15 | -21 | 32 |
| EPS in Rs | 41.16 | 35.57 | 32.80 | 22.62 | 33.01 | 31.66 | -16.45 | -18.10 | 13.91 | -5.78 | 26.81 | -37.55 | 56.07 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 317 | 318 | 293 | 285 | 316 | 320 | 246 | 313 | 341 | 362 | 345 | 333 | 364 |
| Expenses | 281 | 286 | 266 | 267 | 286 | 289 | 227 | 272 | 297 | 315 | 342 | 327 | 338 |
| Operating Profit | 37 | 31 | 27 | 18 | 30 | 30 | 19 | 41 | 44 | 47 | 3 | 6 | 27 |
| OPM % | 12% | 10% | 9% | 6% | 10% | 10% | 8% | 13% | 13% | 13% | 0.9% | 1.7% | 7% |
| Other Income | 2 | 43 | 8 | 9 | 15 | 7 | 17 | 16 | 15 | 58 | 30 | 7 | 13 |
| Interest | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 3 | 3 |
| Depreciation | 15 | 9 | 8 | 8 | 7 | 8 | 8 | 9 | 9 | 7 | 7 | 10 | 10 |
| Profit before tax | 20 | 63 | 26 | 18 | 38 | 29 | 27 | 47 | 51 | 97 | 25 | 1 | 28 |
| Tax % | 32% | 24% | 39% | 45% | 29% | 34% | 19% | 25% | 29% | 22% | 32% | 379% | |
| Net Profit | 14 | 48 | 16 | 10 | 27 | 19 | 22 | 35 | 36 | 75 | 17 | -1 | 23 |
| EPS in Rs | 24.00 | 84.10 | 27.96 | 17.24 | 46.68 | 33.59 | 38.79 | 61.78 | 63.38 | 132.15 | 30.14 | -2.61 | 39.55 |
| Dividend Payout % | 23% | 7% | 20% | 32% | 13% | 21% | 15% | 15% | 14% | 9% | 17% | -192% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | -1.0% | 6.0% | 0.0% |
Shareholding Pattern
Promoters62.23%
FIIs0.84%
DIIs1.65%
Public35.27%
Promoters62.23%
FIIs0.60%
DIIs1.65%
Public35.50%
Promoters62.23%
FIIs0.60%
DIIs1.65%
Public35.51%
Promoters62.23%
FIIs0.58%
DIIs1.65%
Public35.52%
Promoters62.23%
FIIs0.57%
DIIs1.63%
Public35.56%
Promoters62.04%
FIIs0.57%
DIIs2.80%
Public34.59%
Promoters62.13%
FIIs0.98%
DIIs1.67%
Public35.23%
Promoters62.23%
FIIs1.00%
DIIs1.64%
Public35.12%
Promoters62.23%
FIIs0.58%
DIIs1.65%
Public35.52%
Promoters62.23%
FIIs0.57%
DIIs1.63%
Public35.56%
ALBERTDAVD
Holdings Analysis
Key strengths & risk signals
51
Overall
35
Fundamental
68
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
RECOVERY MODE! Current price (791.6) above 200-day but below 50-day.
POSITIVE YEAR! Stock gained 1.3% in the last year.
WEAK MOMENTUM! Limited price growth - -7.6% (1 week), -6.9% (1 month), 12.9% (3 months).
Strengths (3)
BULLISH TREND! 50-day average (828.3) is above 200-day average (736.4) - positive signal.
LOW VOLATILITY! Beta of 0.40 - stable stock, less market risk.
BULLISH SENTIMENT! In last 30 days: 12 up days, 17 down days. Avg volume on up days: 6,382 vs down days: 4,831. Ratio: 1.32x
Fundamental & Technical Analysis
51Overall
35Fundamental
68Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -1.1% (DECLINING, 2/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
3/10
LOW MARGIN! 6.2% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.63% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 35.01% public ownership - moderate retail influence.
Stability Index
4/10
CAREFUL! Company does not have stable profit track. 2 loss-making quarters detected.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (828.3) is above 200-day average (736.4) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (791.6) above 200-day but below 50-day.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
4/10
POSITIVE YEAR! Stock gained 1.3% in the last year.
Volume Sentiment
25/30
BULLISH SENTIMENT! In last 30 days: 12 up days, 17 down days. Avg volume on up days: 6,382 vs down days: 4,831. Ratio: 1.32x
RSI
4/5
APPROACHING OVERSOLD! RSI at 37.4 - watch for reversal.
52W Range
4/5
UPPER HALF! Trading at 60.1% of 52W range - positive territory.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -7.6% (1 week), -6.9% (1 month), 12.9% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.40 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALBERTDAVD | ₹791.60 | 20 | 6.2% | -1.1% | – | +1.3% | 51 | BREAKDOWN | +305.1% | -249.5% | +43.5% | +17.9% |
| MEDICAMEQ | ₹300.90 | 40.6 | 4.7% | 12.0% | -13.4% | +1.1% | 54 | BREAKDOWN | -4.5% | -46.2% | +11.4% | -21.0% |
| AAREYDRUGS | ₹104.10 | 70.8 | 0.9% | 4.5% | 1.7% | +32.7% | 58 | APPROACHING RESISTANCE | -28.6% | -37.5% | -56.4% | -76.5% |
| AMBALALSA | ₹40.60 | 23.9 | 6.6% | 5.8% | 15.9% | +21.3% | 64 | BREAKDOWN | -51.2% | -38.5% | -7.2% | -33.4% |
| VALIANTLAB | ₹119.80 | 42.6 | 5.2% | -10.7% | – | +41.7% | 60 | BREAKDOWN | +1,072.2% | +1,072.2% | +146.4% | +25.3% |
| WANBURY | ₹196.40 | 12.1 | 8.6% | 8.9% | – | -21.7% | 51 | APPROACHING SUPPORT | -76.3% | -85.3% | +1.5% | +0.6% |
| BROOKS | ₹70.10 | 15.6 | 15.9% | 11.0% | – | -52.9% | 62 | BREAKOUT | -118.8% | -220.0% | -9.8% | +13.9% |
| NECLIFE | ₹10.10 | 28.9 | – | – | – | -24.9% | 46 | BREAKDOWN | -75.6% | -77.3% | – | – |
Data from TradeAlone · Updated daily
No news tagged for ALBERTDAVD yet.
